US Stock MarketDetailed Quotes

CDTX Cidara Therapeutics

Watchlist

18.7600
-1.4500-7.17%

Close Dec 2 16:00 ET

205.21MMarket Cap-809P/E (TTM)

Cidara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-2,145.72%-36.7M

-3,777.53%-103.78M

39.03%-6.64M

21.22%-22.43M

39.42%-12.72M

-105.84%-1.63M

123.84%2.82M

53.84%-10.9M

-12.84%-28.47M

-40.89%-21M

Net income from continuing operations

-75.52%-15.99M

-569.47%-91.21M

-442.71%-10.33M

31.72%-22.93M

81.28%-3.21M

-160.80%-9.11M

-3.85%-13.62M

116.48%3.01M

20.92%-33.58M

-2.14%-17.16M

Depreciation and amortization

177.27%61K

128.00%57K

75.00%56K

-17.48%118K

34.48%39K

-40.54%22K

111.36%25K

-89.23%32K

111.63%143K

101.41%29K

Other non cash items

11.90%301K

3,994.83%2.26M

-70.15%220K

26.27%1.24M

118.40%292K

-86.85%269K

-111.09%-58K

73,600.00%737K

6,446.67%982K

-53,000.00%-1.59M

Change In working capital

-441.73%-21.82M

-199.40%-15.59M

117.04%2.61M

-963.44%-3.92M

-261.08%-10.67M

-36.58%6.39M

5,093.38%15.68M

-120.02%-15.32M

-96.86%454K

-214.49%-2.96M

-Change in receivables

-71.80%650K

-77.44%4.66M

144.19%8.97M

-2,083.02%-10.41M

-1,552.09%-13.07M

1,197.62%2.31M

422.35%20.64M

-492.00%-20.29M

-108.20%-477K

46.70%-791K

-Change in inventory

--0

404.40%7.27M

---1.17M

---6.1M

---3.2M

---513K

---2.39M

--0

-Change in prepaid assets

-4,208.99%-26.96M

-68.87%396K

-132.19%-273K

253.07%3.74M

223.26%959K

-27.51%656K

187.91%1.27M

175.71%848K

-965.50%-2.44M

17.41%-778K

-Change in payables and accrued expense

-26.63%3.37M

-44.37%731K

-165.83%-2.27M

877.89%15.39M

131.06%6.03M

928.88%4.59M

215.26%1.31M

425.57%3.45M

244.01%1.57M

1,025.89%2.61M

-Change in other current liabilities

-58.60%-295K

6.23%-286K

32.07%-197K

7.51%-973K

4.95%-192K

36.08%-186K

-7.77%-305K

-5.07%-290K

-168.71%-1.05M

-109.35%-202K

-Change in other working capital

400.85%1.41M

-485.00%-28.36M

-354.86%-2.44M

-295.30%-5.56M

68.22%-1.21M

-104.58%-468K

-522.21%-4.85M

134.22%957K

-66.12%2.85M

-221.32%-3.8M

Cash from discontinued investing activities

Operating cash flow

-2,145.72%-36.7M

-3,777.53%-103.78M

39.03%-6.64M

21.22%-22.43M

39.42%-12.72M

-105.84%-1.63M

123.84%2.82M

53.84%-10.9M

-12.84%-28.47M

-40.89%-21M

Investing cash flow

Cash flow from continuing investing activities

15.87%-106K

75.53%-23K

-327.97%-505K

-1,877.78%-178K

-1,300.00%-126K

-568.75%-107K

-11.90%-94K

-187.80%-118K

-9K

Net PPE purchase and sale

15.87%-106K

--0

75.53%-23K

-327.97%-505K

-1,877.78%-178K

-1,300.00%-126K

-568.75%-107K

-11.90%-94K

-187.80%-118K

---9K

Cash from discontinued investing activities

Investing cash flow

15.87%-106K

--0

75.53%-23K

-327.97%-505K

-1,877.78%-178K

-1,300.00%-126K

-568.75%-107K

-11.90%-94K

-187.80%-118K

---9K

Financing cash flow

Cash flow from continuing financing activities

-182K

91,721.07%239.13M

-100.35%-93K

2,832.28%25.98M

-98.80%8K

76.51%-261K

4,394.11%26.24M

-102.13%-951K

-98.20%664K

Net issuance payments of debt

---75K

---50K

--0

41.65%-2.59M

--0

Net common stock issuance

---107K

91,748.28%239.2M

--0

999.20%25.96M

-99.85%1K

--0

---261K

5,144.60%26.22M

-95.18%2.36M

-98.25%664K

Proceeds from stock option exercised by employees

--0

--21K

--7K

--0

--14K

--0

Net other financing activities

--0

--4K

---43K

----

---720K

--0

Cash from discontinued financing activities

Financing cash flow

---182K

91,721.07%239.13M

-100.35%-93K

2,832.28%25.98M

-98.80%8K

--0

76.51%-261K

4,394.11%26.24M

-102.13%-951K

-98.20%664K

Net cash flow

Beginning cash position

225.93%164.37M

-39.52%29.02M

9.31%35.78M

-47.44%32.73M

-8.30%48.67M

101.66%50.43M

26.35%47.98M

-47.44%32.73M

44.99%62.27M

31.69%53.08M

Current changes in cash

-2,001.31%-36.98M

5,415.53%135.35M

-144.34%-6.76M

110.31%3.05M

36.64%-12.89M

-106.27%-1.76M

118.93%2.45M

162.73%15.25M

-252.88%-29.54M

-192.62%-20.35M

End cash Position

161.73%127.39M

225.93%164.37M

-39.52%29.02M

9.31%35.78M

-8.30%48.67M

101.66%50.43M

26.35%47.98M

-47.44%32.73M

Free cash flow

-1,990.97%-36.8M

-3,922.47%-103.78M

39.35%-6.67M

19.78%-22.94M

38.60%-12.9M

-106.29%-1.76M

122.91%2.72M

53.60%-10.99M

-13.13%-28.59M

-40.95%-21.01M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-2,145.72%-36.7M	-3,777.53%-103.78M	39.03%-6.64M	21.22%-22.43M	39.42%-12.72M	-105.84%-1.63M	123.84%2.82M	53.84%-10.9M	-12.84%-28.47M	-40.89%-21M
Net income from continuing operations	-75.52%-15.99M	-569.47%-91.21M	-442.71%-10.33M	31.72%-22.93M	81.28%-3.21M	-160.80%-9.11M	-3.85%-13.62M	116.48%3.01M	20.92%-33.58M	-2.14%-17.16M
Depreciation and amortization	177.27%61K	128.00%57K	75.00%56K	-17.48%118K	34.48%39K	-40.54%22K	111.36%25K	-89.23%32K	111.63%143K	101.41%29K
Other non cash items	11.90%301K	3,994.83%2.26M	-70.15%220K	26.27%1.24M	118.40%292K	-86.85%269K	-111.09%-58K	73,600.00%737K	6,446.67%982K	-53,000.00%-1.59M
Change In working capital	-441.73%-21.82M	-199.40%-15.59M	117.04%2.61M	-963.44%-3.92M	-261.08%-10.67M	-36.58%6.39M	5,093.38%15.68M	-120.02%-15.32M	-96.86%454K	-214.49%-2.96M
-Change in receivables	-71.80%650K	-77.44%4.66M	144.19%8.97M	-2,083.02%-10.41M	-1,552.09%-13.07M	1,197.62%2.31M	422.35%20.64M	-492.00%-20.29M	-108.20%-477K	46.70%-791K
-Change in inventory	--0	404.40%7.27M	---1.17M	---6.1M	---3.2M	---513K	---2.39M	--0	--0	--0
-Change in prepaid assets	-4,208.99%-26.96M	-68.87%396K	-132.19%-273K	253.07%3.74M	223.26%959K	-27.51%656K	187.91%1.27M	175.71%848K	-965.50%-2.44M	17.41%-778K
-Change in payables and accrued expense	-26.63%3.37M	-44.37%731K	-165.83%-2.27M	877.89%15.39M	131.06%6.03M	928.88%4.59M	215.26%1.31M	425.57%3.45M	244.01%1.57M	1,025.89%2.61M
-Change in other current liabilities	-58.60%-295K	6.23%-286K	32.07%-197K	7.51%-973K	4.95%-192K	36.08%-186K	-7.77%-305K	-5.07%-290K	-168.71%-1.05M	-109.35%-202K
-Change in other working capital	400.85%1.41M	-485.00%-28.36M	-354.86%-2.44M	-295.30%-5.56M	68.22%-1.21M	-104.58%-468K	-522.21%-4.85M	134.22%957K	-66.12%2.85M	-221.32%-3.8M
Cash from discontinued investing activities
Operating cash flow	-2,145.72%-36.7M	-3,777.53%-103.78M	39.03%-6.64M	21.22%-22.43M	39.42%-12.72M	-105.84%-1.63M	123.84%2.82M	53.84%-10.9M	-12.84%-28.47M	-40.89%-21M
Investing cash flow
Cash flow from continuing investing activities	15.87%-106K	0	75.53%-23K	-327.97%-505K	-1,877.78%-178K	-1,300.00%-126K	-568.75%-107K	-11.90%-94K	-187.80%-118K	-9K
Net PPE purchase and sale	15.87%-106K	--0	75.53%-23K	-327.97%-505K	-1,877.78%-178K	-1,300.00%-126K	-568.75%-107K	-11.90%-94K	-187.80%-118K	---9K
Cash from discontinued investing activities
Investing cash flow	15.87%-106K	--0	75.53%-23K	-327.97%-505K	-1,877.78%-178K	-1,300.00%-126K	-568.75%-107K	-11.90%-94K	-187.80%-118K	---9K
Financing cash flow
Cash flow from continuing financing activities	-182K	91,721.07%239.13M	-100.35%-93K	2,832.28%25.98M	-98.80%8K	0	76.51%-261K	4,394.11%26.24M	-102.13%-951K	-98.20%664K
Net issuance payments of debt	---75K	---75K	---50K	--0	--0	--0	--0	--0	41.65%-2.59M	--0
Net common stock issuance	---107K	91,748.28%239.2M	--0	999.20%25.96M	-99.85%1K	--0	---261K	5,144.60%26.22M	-95.18%2.36M	-98.25%664K
Proceeds from stock option exercised by employees	--0	--0	--0	--21K	--7K	--0	--0	--14K	--0	--0
Net other financing activities	--0	--4K	---43K	----	----	----	----	----	---720K	--0
Cash from discontinued financing activities
Financing cash flow	---182K	91,721.07%239.13M	-100.35%-93K	2,832.28%25.98M	-98.80%8K	--0	76.51%-261K	4,394.11%26.24M	-102.13%-951K	-98.20%664K
Net cash flow
Beginning cash position	225.93%164.37M	-39.52%29.02M	9.31%35.78M	-47.44%32.73M	-8.30%48.67M	101.66%50.43M	26.35%47.98M	-47.44%32.73M	44.99%62.27M	31.69%53.08M
Current changes in cash	-2,001.31%-36.98M	5,415.53%135.35M	-144.34%-6.76M	110.31%3.05M	36.64%-12.89M	-106.27%-1.76M	118.93%2.45M	162.73%15.25M	-252.88%-29.54M	-192.62%-20.35M
End cash Position	161.73%127.39M	225.93%164.37M	-39.52%29.02M	9.31%35.78M	9.31%35.78M	-8.30%48.67M	101.66%50.43M	26.35%47.98M	-47.44%32.73M	-47.44%32.73M
Free cash flow	-1,990.97%-36.8M	-3,922.47%-103.78M	39.35%-6.67M	19.78%-22.94M	38.60%-12.9M	-106.29%-1.76M	122.91%2.72M	53.60%-10.99M	-13.13%-28.59M	-40.95%-21.01M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Heat List

Overall

No Data